Francesco Berlanda Scorza Selected Research

Influenza Vaccines (Influenza Vaccine)

1/2019	Meeting report: Convening on the influenza human viral challenge model for universal influenza vaccines, Part 1: Value; challenge virus selection; regulatory, industry and ethical considerations; increasing standardization, access and capacity.
10/2016	Chemistry, manufacturing and control (CMC) and clinical trial technical support for influenza vaccine manufacturers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Berlanda Scorza Research Topics

Disease

6	Infections 05/2024 - 01/2013
5	Human Influenza (Influenza) 01/2019 - 01/2016
3	Bacillary Dysentery (Shigellosis) 04/2024 - 02/2022
1	Hemolysis 01/2024
1	Neglected Diseases 11/2022
1	Typhoid Fever (Typhoid) 11/2022
1	Virus Diseases (Viral Diseases) 01/2019
1	Pain (Aches) 01/2018
1	Chlamydia Infections 01/2013

Drug/Important Bio-Agent (IBA)

11	VaccinesIBA 05/2024 - 01/2016
3	AntibodiesIBA 01/2024 - 01/2013
2	O Antigens (O Antigen)IBA 02/2022 - 04/2021
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2019 - 10/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2024
1	streptolysin OIBA 01/2024
1	glyceryl methyl methacrylateIBA 09/2023
1	Carrier Proteins (Binding Protein)IBA 07/2023
1	CarbohydratesIBA 07/2023
1	Complement System Proteins (Complement)IBA 12/2022
1	Conjugate VaccinesIBA 11/2022
1	CRM197 (non-toxic variant of diphtheria toxin)IBA 11/2022
1	LipopolysaccharidesIBA 02/2022
1	SiderophoresIBA 04/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2021
1	Virulence Factors (Pathogenicity Factors)IBA 04/2021
1	NucleoproteinsIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	EpitopesIBA 01/2013

Therapy/Procedure

1	Therapeutics 05/2024